Results

Total Results: 3,085 records

Showing results for "drugs".

241. Final Report: Using Risk Models To Improve Safety With Dispensing High-Alert Medications in Community Pharmacies (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/cohen-report.pdf
     January 01, 2024 - Errors with these drugs are not necessarily more common, but the consequences are more devastating. … Examples of risk factors with these drugs can be found in Table 9 (Appendix A). … This PADE was also applicable to any medication, not just the high-alert drugs under study. … Which drugs cause preventable admissions to hospital? A systematic review. … Accessed February 28, 2009. 79 Top 200 brand drugs by units in 2007. Drug Topics Digital Edition.

242. Event Investigation and Analysis Guide: Appendix A | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/capacity/candor/modules/guide4/apa.html
     February 01, 2017 - "garbage in, garbage out." 5th Why : Why do you think the pharmacists or technicians who put the drugs

243. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=421
     January 01, 2024 - The researchers sought to determine whether biological drugs are associated with an increased risk of … serious infection compared with traditional disease-modifying antirheumatic drugs (DMARDs). … They found that standard-dose and high-dose biological drugs, with or without traditional DMARDs, are … serious infections in rheumatoid arthritis compared with traditional DMARDs, although low-dose biological drugs

244. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=307
     January 01, 2024 - AHRQ Author: Kirby J, Zodet M Association of insurance gains and losses with access to prescription drugs … Their findings that unmet need for prescription drugs declined among initially uninsured adults who gained … that having and maintaining health insurance is a key protection against unmet need for prescription drugs … Association of insurance gains and losses with access to prescription drugs.

245. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=337
     January 01, 2024 - Cancer, Practice Patterns Flory J Will cardiovascular outcomes data on newer diabetes drugs … opportunity to champion public health because the agency exerts great influence on how type 2 diabetes drugs … improve the health of patients with diabetes who now face many uninformed choices between newer and older drugs … Will cardiovascular outcomes data on newer diabetes drugs bury the older agents?

246. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=463
     January 01, 2024 - investigators examined insurers' role in maintaining the affordability and accessibility of specialty drugs … , a point at which patients were far less likely to abandon therapy with biologic anti-inflammatory drugs … or with drugs for multiple sclerosis. … cost sharing, coupons may also circumvent efforts to encourage patients to use the most cost-effective drugs

247. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=451
     January 01, 2024 - Healthcare Delivery, Health Systems, Primary Care Shahid H , Singh JA Investigational drugs … This review discusses ten new drugs in preclinical and early clinical trials for hyperuricemia, their … Investigational drugs for hyperuricemia. … Expert Opin Investig Drugs 2015;24(8):1013-30. doi: 10.1517/13543784.2015.1051617..

248. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=443
     January 01, 2024 - After incretin mimetic medications (IMs), a new class of diabetes drugs, were introduced in 2005, researchers … Effectiveness, Outcomes Daubresse M , Alexander GC The uphill battle facing antiobesity drugs … contribute to the irony that despite American’s penchant for high rates of pharmaceutical use, obesity drugs … The uphill battle facing antiobesity drugs.

249. Introduction to Synthetic Healthcare Database for Research (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Introduction-2023Dec.pdf
     December 01, 2023 - • Synthetic diagnoses, procedures, and drugs were generated so that univariate distributions of these … in the synthetic data generation process, the frequencies of synthetic diagnoses, procedures, and drugs … While these differences are usually small, they may be pronounced for rare diseases, procedures, or drugs … characters), rare procedures beyond the Clinical Classifications Software category level, and rare drugs

250. County-Level Hospitalization Rates Show Impact of Opioids, Other Substances | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/605.html
     March 01, 2018 - allows users to compare county-level hospitalization rates for opioids, alcohol, stimulants and other drugs … A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase

251. CHIPRA 218: Section 5, Table 6 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-218-section-5-table-6.pdf
     January 01, 2009 - Pharmacological pain management consists of the use of nonsteroidal anti‐inflammatory drugs (NSAIDs … Pediatr Drugs 2003; 5(4):229‐ 241.

252. CHIPRA 223: Section 5, Table 4 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-223-section-5-table-4.pdf
     January 01, 2009 - Pharmacological pain management consists of the use of nonsteroidal anti‐inflammatory drugs (NSAIDs … Pediatr Drugs 2003; 5(4):229‐ 241.

253. Table 5. Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
     April 01, 2014 - Pharmacological pain management consists of the use of nonsteroidal anti‐inflammatory drugs (NSAIDs … Pediatr Drugs 2003; 5(4):229‐241.

254. ACA-Covered Preventive Health Services for Women | Agency for Healthcare Research and Quality
     www.ahrq.gov/ncepcr/tools/healthier-pregnancy/fact-sheets/preventive-health-services.html
     May 01, 2015 - prescribed by a health care provider for women with reproductive capacity (not including abortifacient drugs

255. Analysis of Patient Safety: Converting Complex Pediatric Chemotherapy Ordering Processes from Paper to Electronic Systems (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Baker_107.pdf
     March 30, 2008 - Drugs received from the pharmacy are compared against the orders and electronic medication administration … These intermittent orders (IV fluids, multiple IV drugs admixed in the same admixture bag, or single … IV drugs) include an infusion rate, an amount of time over which to infuse each dose, and the frequency … Elimination of the use of acronyms, brand names, or abbreviations of chemotherapy drugs. 5. … Distinct labeling and packaging of chemotherapy drugs. 9.

256. Routine Hysterectomies Uncover Unexpected Cancer | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/661.html
     April 01, 2019 - Report Summarizes Effectiveness of Drugs To Treat Osteoporosis . … Report Summarizes Effectiveness of Drugs To Treat Osteoporosis A new AHRQ-supported report summarizes

257. Safe Medication Administration: Facilitator Guide | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/medication/safe-medication-fac-guide.html
     July 01, 2023 - each unit to consider as it establishes processes for ensuring safe medication administration of these drugs … Medications Say: High-alert medications are defined by the Institute for Safe Medication Practices as "drugs … Although mistakes are not necessarily more common with these drugs, the consequences of errors are more … medications require special safeguards such as the following: Improving access to information about these drugs

258. Final Progress Report: Risk Analysis of Pediatric Chemotherapy Processes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/14295%20Shenep-draft-1.pdf
     June 01, 2005 - keyed by our Protocol Office staff based on signed consents, before certain order sets or research drugs … distinguish between look-alike or (Only applicable routes sound-alike of administration specific drugs … Review the road map and/or protocol for the correct week and drugs. 2. Recalculate the dosage. … Reconstitute the appropriate amount of commonly used drugs. 2. … Sequence: 7 Calculate Dosage(s) Accomplished by: Pharmacist Story: Dosages are calculated on drugs

259. Reporting of Adverse Drug Events: Examination of a Hospital Incident Reporting System (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Desikan.pdf
     March 01, 2002 - DoseChecker routinely screens approximately 50 drugs that are either potentially toxic or typically … In RMEES, the drugs most frequently reported involving preventable adverse drug events were heparin, … insulin, vancomycin, and morphine (all from the top four drug classes of RMEES), while the drugs most … More than 50 percent of the preventable adverse drug events in RMEES were associated with just 14 drugs … , while no such pattern was noted for the drugs involved in PHRED events.

260. Medication Discrepancies and Potential Adverse Drug Events During Transfer of Care from Hospital to Home | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/resources/liability/neumiller.html
     August 01, 2017 - Drugs resulting in serious potential ADEs included exemestane, enoxaparin, warfarin, and sublingual nitroglycerin … Minor potential ADEs most often involved OTC agents, antacids, cholesterol lowering drugs, allergic rhinitis … agents, nonsteroidal anti-inflammatory drugs (NSAIDs), and thyroid supplements. … common medication classes involved were antibiotics, antidepressants, antipsychotics, cardiovascular drugs